Skip to content

Management of Adverse Events Associated with Immunotherapy

Immunotherapy is a growing treatment option for patients with cancer and the indications for immunotherapy continue to expand. It is used to treat patients in the adjuvant setting as well as patients with metastatic cancer. The advantage of immunotherapy is it offers durable responses not often seen with traditional chemotherapy. However, these medications are associated with unique immune-mediated adverse events. The treatments for these adverse events are as unique as the adverse events themselves. The information provided in this presentation will provide pharmacists the tools necessary to provide that care.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the mechanism of action of immunotherapy.
  • Identify serious adverse events associated with immunotherapy.
  • Discuss treatment options for the management of serious immune-mediated adverse events.
  • Recognize long term potential adverse events associated with immunotherapy.


Suzanne Stevens, PharmD, BCOP
Suzanne is a Clinical Oncology Supervisor at Wentworth-Douglass Hospital in Dover, NH. Previous to this she worked at Massachusetts General Hospital North Shore Cancer Center as a clinical pharmacist and Portsmouth Regional Hospital as an oncology pharmacist. She received her Bachelor’s in Pharmacy from MCPHS in 1998 and returned in 2009 to earn her PharmD by attending the Post BS PharmD Program, graduating in 2011. She has spent the majority of her 20-year pharmacy career in the ambulatory oncology setting, obtaining Board Certification in Oncology Pharmacy in 2006.


ACPE logo

Release Date: September 16, 2020
Expiration Date: September 16, 2021
Contact Hours: 1.0
Universal Activity Number: ACPE UAN: 0026-0000-20-202-H01-P
ACPE Topic Designator: Drug Therapy

Registration Fee: Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.